Methenolone Enanthate

Drug #2129

Methenolone Enanthate is a dihydrotestosterone based anabolic steroid.It is an ester derivative of methenolone.

← Previous drug Next drug →

Primary Characteristics

Molecular Weight: 414.62 · Non-proprietary name: Methenolone Enanthate.

Molecular structure of Methenolone Enanthate

Pharmacokinetics

Elimination: plasma half-life is 10.5 days.

Indications

Methenolone Enanthate is primarily indicated in conditions like Anabolic steroid, Aplastic anemia, Breast cancer, Post menopausal breast cancer (with glucocorticoid therapy).

Contraindications

Methenolone Enanthate is contraindicated in conditions like Cardiovascular disease, Pregnancy, Breast carcinoma.

Dosage

Methenolone Enanthate's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
100 mg	100 mg	—	IM	Every 2 weeks for osteoporosis.
200 mg	200 mg	—	IM	Every 2 or 3 weeks in progressive breast cancer.
125 mg	125 mg	—	PO	This dose should be given weekly. In aplastic anaemia.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Methenolone Enanthate is known to cause more or less tolerable side effects which are usually transient. These include Acne, Baldness, Hair growth, Hirsutism , Oily skin.

Warnings / Precautions

In adult males, spermatogenesis may be inhibited, in boys there may be signs of premature puberty. Non-adult patients should be monitored for accelerated bone maturation by X-ray. Impairment of liver function is less frequent than with a 17alpha-alkylated medicines. In men, regular examinations of the prostate should be carried out prophylactically to exclude a malignant tumour.

Available Brands

None recorded.

Drug Classification

1.18.11 — Anabolic drugs